Together with our clinical findings (Fig. 4), these data indicate that PEDF might activate FFA biosynthesis pathway in HCC cells, cause elevated FFA and TG levels, and therefore promote HCC progression. This evidence concerns the gene SERPINF1 and hepatocellular carcinoma.